Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancer.

There is no fulltext present in this item.

Title:	Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancer.
Author(s):	Verwimp-Hoeks, M.P.; Herpen, C.M.L. van ; Burger, D.M.
Publication year:	2012
Source:	Annals of Oncology, vol. 23, iss. 3, (2012), pp. 801-802
ISSN:	0923-7534
DOI:	https://doi.org/10.1093/annonc/mdr597
Annotation:	1 maart 2012
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/109725
Display more details
Subject:	N4i 3: Poverty-related infectious diseases NCEBP 13: Infectious diseases and international health NCMLS 2: Immune Regulation ONCOL 3: Translational research
Organization:	Medical Oncology Clinical Pharmacy
Journal title:	Annals of Oncology
Volume:	vol. 23
Issue:	iss. 3
Page start:	p. 801
Page end:	p. 802